We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+15.64%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$107M
AUM Growth
+$505K
Cap. Flow
-$4.95M
Cap. Flow %
-4.64%
Top 10 Hldgs %
45.12%
Holding
91
New
3
Increased
11
Reduced
50
Closed
7

Top Buys

Rank Stock Value
1
BKSY icon
BlackSky Technology
BKSY
+$1.86M
2
MDXH icon
MDxHealth
MDXH
+$840K
3
BDSX icon
Biodesix
BDSX
+$533K
4
ELUT icon
Elutia
ELUT
+$298K
5
ORN icon
Orion Group Holdings
ORN
+$231K

Sector Composition

Rank Sector Weight
1 Healthcare 60.78%
2 Technology 24.51%
3 Communication Services 5.19%
4 Consumer Staples 3.8%
5 Industrials 2.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$431B
$1.3M 1.21%
6,558
-1,425
-18% -$266K
BDSX icon
27
Biodesix
BDSX
$236M
$1.29M 1.21%
36,239
+15,500
+75% +$533K
VCEL icon
28
Vericel Corp
VCEL
$2.37B
$1.24M 1.16%
29,250
-2,000
-6% -$95.2K
MRK icon
29
Merck
MRK
$316B
$1.22M 1.14%
10,750
-1,175
-10% -$140K
PFE icon
30
Pfizer
PFE
$145B
$1.16M 1.09%
40,109
-5,566
-12% -$162K
BKSY icon
31
BlackSky Technology
BKSY
$1.04B
$1.11M 1.04%
+235,000
New +$1.86M
AAPL icon
32
Apple
AAPL
$4.52T
$1.08M 1.02%
4,650
TCMD icon
33
Tactile Systems Technology
TCMD
$680M
$1.01M 0.95%
69,000
-8,500
-11% -$110K
VFF icon
34
Village Farms International
VFF
$242M
$1.01M 0.94%
1,083,500
ATEC icon
35
Alphatec Holdings
ATEC
$1.59B
$1M 0.94%
180,667
+100
+0.1% +$768
SKYT
36
DELISTED
SkyWater Technology
SKYT
$951K 0.89%
104,750
-7,000
-6% -$58.4K
CSTL icon
37
Castle Biosciences
CSTL
$953M
$931K 0.87%
32,640
+1,550
+5% +$39.5K
GILD icon
38
Gilead Sciences
GILD
$168B
$917K 0.86%
10,933
-1,500
-12% -$114K
CIEN icon
39
Ciena
CIEN
$58.2B
$908K 0.85%
14,750
-2,000
-12% -$105K
TGT icon
40
Target
TGT
$67.3B
$857K 0.8%
5,500
-1,775
-24% -$264K
ATRC icon
41
AtriCure
ATRC
$1.98B
$840K 0.79%
29,950
-500
-2% -$12.3K
OPRX icon
42
OptimizeRx
OPRX
$129M
$783K 0.73%
101,363
-1,000
-1% -$8.89K
BMY icon
43
Bristol-Myers Squibb
BMY
$135B
$750K 0.7%
14,491
-2,500
-15% -$117K
COP icon
44
ConocoPhillips
COP
$144B
$747K 0.7%
7,100
-900
-11% -$98.8K
T icon
45
AT&T
T
$160B
$742K 0.7%
33,742
-5,134
-13% -$102K
PLUS icon
46
ePlus
PLUS
$2.54B
$738K 0.69%
7,500
-1,000
-12% -$88K
BLZE icon
47
Backblaze
BLZE
$1.19B
$683K 0.64%
106,835
APPS icon
48
Digital Turbine
APPS
$1.15B
$664K 0.62%
216,200
+32,500
+18% +$87.6K
BAX icon
49
Baxter International
BAX
$14.7B
$662K 0.62%
17,425
-3,084
-15% -$113K
USB icon
50
US Bancorp
USB
$100B
$622K 0.58%
13,600
-384
-3% -$16.8K

Similar funds

Perkins Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Perkins Capital Management held 91 positions worth $107M, up 0.48% from $106M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perkins Capital Management withdrew a net $4.95M in Q3 2024, closing 7 positions and reducing 50 holdings. Its most notable exit was Augmedix, Inc. Common Stock, an estimated $1.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Perkins Capital Management opened a new position in BlackSky Technology worth $1.11M.

  • Perkins Capital Management's largest Q3 2024 buy was BlackSky Technology: 235,000 shares worth $1.11M.
  • Perkins Capital Management added most to MDxHealth in Q3 2024, an estimated $840K increase.
  • Perkins Capital Management's biggest Q3 2024 reduction was Airgain, cutting an estimated $941K.
  • Perkins Capital Management fully exited Augmedix, Inc. Common Stock in Q3 2024, selling an estimated $1.25M.
  • Perkins Capital Management's ten largest holdings make up 45% of its $107M portfolio in Q3 2024.
  • Perkins Capital Management opened 3 new positions and closed 7 in Q3 2024.
  • Perkins Capital Management's portfolio value rose 0.48% quarter-over-quarter to $107M.

Based on Perkins Capital Management's 13F filing for Q3 2024, filed 31 Oct 2024.